首页> 外文期刊>Bone marrow transplantation >Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality.
【24h】

Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality.

机译:同种异体骨髓移植(BMT)后淋巴细胞亚群的恢复:CD4 +细胞计数和移植相关的死亡率。

获取原文
获取原文并翻译 | 示例
       

摘要

To assess the kinetics of lymphocyte subset recovery, 758 allografted patients were monitored by surface markers (CD3, CD4, CD8, CD56), with a 5-year follow-up. The donor was a matched sibling donor (MSD) (n=502) or an alternative donor (family mismatched or unrelated, AD) (n=256). The stem cell source was bone marrow for all patients. CD4+ cell recovery was influenced -- in univariate analysis -- by three factors: donor type, patient age and GvHD. This was not the case for CD8+ and CD56+ cells. The median CD4+ cell count on day +35 after HSCT was 86/mul. Patients achieving this CD4+ cell count had significantly lower transplant-related mortality (TRM) compared to patients who did not achieve this CD4+ cell count (20 vs 39%, P=0.00001), due to a lower risk of lethal infections (24 vs 47%, P=0.0003). In multivariate analysis MSD (RR 3.45, P=0.0001) and recipient age less than 16 years (RR 3.23, P=0.003) were significantly associated with a better CD4+ cell recovery. CD4+ counts on day +35 was predicted TRM (RR=1.97, P=0.0017) together with acute GvHD grade II-IV (RR 1.59, P=0.0097). No difference of TRM was observed for CD8+ and CD56+ cell counts.
机译:为了评估淋巴细胞亚群恢复的动力学,通过表面标记(CD3,CD4,CD8,CD56)监测了758名同种异体移植患者,并进行了5年的随访。供体是匹配的同胞供体(MSD)(n = 502)或替代供体(家庭不匹配或不相关的AD)(n = 256)。所有患者的干细胞来源均为骨髓。在单因素分析中,CD4 +细胞的恢复受到三个因素的影响:供体类型,患者年龄和GvHD。 CD8 +和CD56 +细胞不是这种情况。 HSCT后第35天的CD4 +细胞计数中值为86 / mul。与未达到此CD4 +细胞计数的患者相比,达到此CD4 +细胞计数的患者的移植相关死亡率(TRM)明显较低(20 vs 39%,P = 0.00001),因为致命感染的风险较低(24 vs 47 %,P = 0.0003)。在多变量分析中,MSD(RR 3.45,P = 0.0001)和接受者年龄小于16岁(RR 3.23,P = 0.003)与更好的CD4 +细胞恢复显着相关。预测+35天的CD4 +计数为TRM(RR = 1.97,P = 0.0017)以及急性GvHD II-IV级(RR 1.59,P = 0.0097)。对于CD8 +和CD56 +细胞计数,未观察到TRM的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号